Moxetumomab Pasudotox-tdfk and Suclear
Determining the interaction of Moxetumomab Pasudotox-tdfk and Suclear and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Suclear, Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Sucralfate
- Moxetumomab Pasudotox-tdfk-Sucralfate Oral Suspension
- Moxetumomab Pasudotox-tdfk-Sucralfate Suspension
- Moxetumomab Pasudotox-tdfk-Sucralfate Tablet
- Moxetumomab Pasudotox-tdfk-Sucralfate Tablets
- Moxetumomab Pasudotox-tdfk-Sucrets 4-Hour Cough Drops
- Suclear-Moxetumomab pasudotox-tdfk Intravenous
- Suclear-Moxifloxacin
- Suclear-Moxifloxacin (Systemic)
- Suclear-Moxifloxacin Hydrochloride
- Suclear-Moxifloxacin Injection
- Suclear-Moxifloxacin Intravenous